00008-0100
Besponsa
Inotuzumab Ozogamicin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
Inotuzumab Ozogamicin
0.25
mg/mL
00008-0100-01
1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01) > 4 mL in 1 VIAL, SINGLE-DOSE
Aug. 18, 2017
Immunotherapy
Drug Antibody Conjugate
CD22
 
 
In Use